SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042486
Filing Date
2023-08-14
Accepted
2023-08-14 16:37:25
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrt-20230630.htm   iXBRL 10-Q 2176822
2 EX-3.1 tcrt-ex3_1.htm EX-3.1 83950
3 EX-31.1 tcrt-ex31_1.htm EX-31.1 16567
4 EX-32.1 tcrt-ex32_1.htm EX-32.1 8760
  Complete submission text file 0000950170-23-042486.txt   7297796

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrt-20230630_pre.xml EX-101.PRE 379016
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrt-20230630_cal.xml EX-101.CAL 33003
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrt-20230630_lab.xml EX-101.LAB 486409
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrt-20230630_def.xml EX-101.DEF 292606
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrt-20230630.xsd EX-101.SCH 62095
52 EXTRACTED XBRL INSTANCE DOCUMENT tcrt-20230630_htm.xml XML 916103
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 231171236
SIC: 2834 Pharmaceutical Preparations